Flurbiprofen
Specifications
5104-49-4CAS Number
225-827-6EC Number
2-(3-fluoro-4-phenylphenyl)propanoic acidIUPAC Name
C15H13FO2Chemical Formula
244.26 g/molMolecular Weight
flurbiprofen; 5104-49-4; Ansaid; Froben; Antadys; 2-(3-fluoro-4-phenylphenyl)propanoic acid; 2-(2-fluorobiphenyl-4-yl)propanoic acid; Cebutid; Flubiprofen; Flurbiprofene; Flurbiprofeno; 3-Fluoro-4-phenylhydratropic acid; Zepolas; Flurbiprofenum; BTS-18322; U-27182; BTS 18322; (+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid; 2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid; DTXSID0037231; 5GRO578KLP; BTS 18,322; NSC-757037; CHEBI:5130; U-27,182; DTXCID8017231; NSC685701; Fluriproben; (1,1'-Biphenyl)-4-acetic acid, 2-fluoro-alpha-methyl-, (+-)-; Froben Sr; Strefen; Novo Flurprofen; Nu Flurbiprofen; Apo Flurbiprofen; Rinol-STroche; ratio Flurbiprofen; RefChem:55218; 2-Fluoro-alpha-methyl(1,1'-biphenyl)-4-acetic acid; Antiphlamine Pain Relieving; M01AE09; M02AA19; R02AX01; S01BC04; BTS18322; (2RS)-2-(2-Fluorobiphenyl-4-yl)propanoic acid; 225-827-6; Flurofen; Ocufen; Flurbiprofene [INN-French]; Flurbiprofenum [INN-Latin]; Flurbiprofeno [INN-Spanish]; MFCD00079303; 2-(2-FLUORO-[1,1'-BIPHENYL]-4-YL)PROPANOIC ACID; FP 70; Stayban; 51543-38-5; Adfeed; U 27182; 2-(2-Fluoro-4-biphenylyl)propionic acid; (+/-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid; 2-(2-Fluoro-1,1'-biphenyl-4-yl)propanoic acid; CHEMBL563; 2-Fluoro-alpha-methyl-4-biphenylacetic acid; MLS000040873; 2-(3-fluoro-4-phenyl-phenyl)propanoic acid; Flugalin; Anmetarin; SMR000042823; Yakuban; 2-(2-Fluoro[1,1'-biphenyl]-4-yl)propanoic acid; Ocuflur; 2-(2-Fluorobiphenyl-4-yl)propionic Acid; Flurbiprofen (Ansaid); Ansaid (TN); CCRIS 3708; (S)-2-(2-fluorobiphenyl-4-yl)propanoic acid; SR-01000003043; FLP; (R)-Flurbiprofen;MPC7869; EINECS 225-827-6; (+-)-2-(2-Fluoro-4-biphenylyl)propionic acid; UNII-5GRO578KLP; U 27,182; Flurbiprofen; (2RS)-2-(2-Fluorobiphenyl-4-yl)propanoic acid; Flurbiprofen O; MKS-11; rac-Flurbiprofen; s1679; Froben;; Flurbiprofen CRS; 2-(2-FLUORO-4-BIPHENYLYL)PROPANOIC ACID; NCGC00016654-01; (+-)Flurbiprofen; CAS-5104-49-4; EINECS 257-262-6; Ocufen (Salt/Mix); [1,1'-Biphenyl]-4-acetic acid, 2-fluoro-?-methyl-; (1)-2-Fluoro-alpha-methyl(1,1'-biphenyl)-4-acetic acid; Flurbiprofen (NSAID); Flurbiprofen [USAN:USP:INN:BAN:JAN]; Spectrum_001096; Flurbiprofen (Standard); Opera_ID_777; Prestwick0_000917; Prestwick1_000917; Prestwick2_000917; Prestwick3_000917; Spectrum2_001025; Spectrum3_000435; Spectrum4_000558; Spectrum5_000720; FLURBIPROFEN [MI]; F0371; (.+/-.)-Flurbiprofen; Flurbiprofendl-Flurbiprofen; FLURBIPROFEN [INN]; FLURBIPROFEN [JAN]; Epitope ID:613431; 4-Biphenylacetic acid, 2-fluoro-alpha-methyl-; FLURBIPROFEN [USAN]; SCHEMBL2248; FLURBIPROFEN [VANDF]; 4-Biphenylacetic acid, 2-fluoro-.alpha.-methyl-; BSPBio_000794; BSPBio_002050; FLURBIPROFEN [MART.]; KBioGR_001255; KBioSS_001576; MLS000028441; MLS000758198; MLS001201729; MLS001401361; MLS006011431; MLS006011931; DivK1c_000804; FLURBIPROFEN [USP-RS]; FLURBIPROFEN [WHO-DD]; SPECTRUM1500308; 2-(2-fluoro-[1,1'-biphenyl-4-yl])propanoic acid; SPBio_001209; SPBio_002983; BPBio1_000874; GTPL4194; orb1224876; orb1310752; SCHEMBL10029029; Flurbiprofen (JP18/USP/INN); HMS502I06; KBio1_000804; KBio2_001576; KBio2_004144; KBio2_006712; KBio3_001270; SYTBZMRGLBWNTM-UHFFFAOYSA-; [1,1'-Biphenyl]-4-acetic acid, 2-fluoro-.alpha.-methyl-; MSK7164; NINDS_000804; FLURBIPROFEN [ORANGE BOOK]; HMS1570H16; HMS1920O20; HMS2051A05; HMS2090I06; HMS2091F21; HMS2097H16; HMS2232I08; HMS3259I12; HMS3268E10; HMS3370N14; HMS3371I05; HMS3393A05; HMS3414N17; HMS3649K11; HMS3655G19; HMS3678N15; HMS3714H16; HMS5079N10; Pharmakon1600-01500308; FLURBIPROFEN [EP MONOGRAPH]; 2-FLUORO-[1,1'-BIPHENYL]-4-(ALPHA-METHYL)ACETIC ACID; FLURBIPROFEN [USP MONOGRAPH]; Tox21_110547; Tox21_302353; BBL010980; BDBM50074922; CCG-40243; EBC-26294; HB3049; HY-10582R; MSK7164-100M; NSC755404; NSC757037; SBB067242; STK802101; Flurbiprofen, cyclooxygenase inhibitor; AKOS004119934; AKOS016340701; MSK7164-1000M; AC-8106; CCG-100759; DB00712; FF23507; KS-5035; NC00009; NC00563; NSC 757037; NSC-685701; NSC-755404; 2(2-Fluoro-4-biphenylyl)propionic acid; Flurbiprofen for peak identification CRS; IDI1_000804; NCGC00018157-03; NCGC00018157-04; NCGC00018157-05; NCGC00018157-08; NCGC00018157-11; NCGC00018157-13; NCGC00025287-03; NCGC00025287-04; NCGC00255457-01; HY-10582; NCI60_030812; SY057091; 2 -(2-fluoro-4-biphenylyl)propionic acid; 2-(2-fluoro-4-biphenylyl)-propionic acid; 2-(2-fluoro-biphenyl-4-yl)propionic acid; SBI-0051387.P003; DB-051888; 2-(2-fluoro-biphenyl-4-yl)-propionic acid; AB00051999; F4481; Flurbiprofen Solution in Methanol, 100ug/mL; NS00003058; ST50825909; alpha-methyl-2-fluoro-4-biphenylylacetic acid; Flurbiprofen Solution in Methanol, 1000ug/mL; (RS)-2-(2-fluorobiphenyl-4-yl)propionic acid; 2-Fluoro-.alpha.-methyl-4-biphenylacetic acid; BIM-0051387.0001; C07013; D00330; AB00051999-17; AB00051999_18; EN300-7479231; 2-fluoro--methyl-(1,1'-biphenyl)-4-acetic acid; AO-295/42284050; F463477; Q419890; (.+/-.)-2-(2-Fluoro-4-biphenylyl)propionic acid; (r/s)-2-fluoro-alpha-methyl-4-biphenylacetic acid; SR-01000003043-2; SR-01000003043-5; SR-01000003043-6; 2-(2-fluoro-[1,1''-biphenyl-4-yl])propanoic acid; 2-(2-Fluoro[1,1'-biphenyl]-4-yl)propanoic acid #; BRD-A86044036-001-05-9; BRD-A86044036-001-26-5; BRD-A86044036-001-27-3; SR-01000003043-14; (+/-)-2-(2-FLUORO-4-BIPHENYLYL)PROPIONIC ACID; (.+/-.)-2-Fluoro-.alpha.-methyl-4-biphenylacetic acid; 2-Fluoro-.alpha.-methyl(1,1'-biphenyl)-4-acetic acid; 2-fluoro-alpha-methyl-(1,1''-biphenyl)-4-acetic acid; 2-Fluoro-alpha-methyl-[1,1'-biphenyl]-4-a cetic acid; 2-Fluoro-I<<-methyl-[1,1'-biphenyl]-4-a cetic acid; Z2216885233; (+/-)-2-FLUORO-.ALPHA.-METHYL-4-BIPHENYLACETIC ACID; [1,1'-Biphenyl]-4-acetic acid, 2-fluoro-a-methyl-, (+/-)-; Flurbiprofen, European Pharmacopoeia (EP) Reference Standard; (1,1'-Biphenyl)-4-acetic acid, 2-fluoro-alpha-methyl-, (+/-)-; [1,1'-Biphenyl]-4-acetic acid, 2-fluoro-a-methyl-, (A+/-)-; Flurbiprofen, United States Pharmacopeia (USP) Reference Standard; [1,1'-Biphenyl]-4-acetic acid, 2-fluoro-.alpha.-methyl-, (.+/-.)-; 2-[2-Fluoro-[1,1 inverted exclamation mark -biphenyl]-4-yl]propanoic Acid; (1,1'-BIPHENYL)-4-ACETIC ACID, 2-FLUORO-.ALPHA.-METHYL-, (+/-)-; Flurbiprofen, 2-(2-Fluorobiphenyl-4-yl)propionic acid, 3-Fluoro-4-phenylhydratropic acid; Flurbiprofen, Pharmaceutical Secondary Standard; Certified Reference Material; 2-Fluoro-4-Iodo-1-isothiocyanatobenzene; 2-Fluoro-4-iodo-1-isothiocyanatobenzene; 2-Fluoro-4-iodophenyl isothiocyanate;; InChI=1/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18)Synonyms
Products Containing Flurbiprofen
케펨액티브플라스타(플루르비프로펜)제일파프탑플러스플라스타(플루르비프로펜)트라스트루비플라스타(플루르비프로펜)조인업더블플라스타(플루르비프로펜)파워스탑플라스타40밀리그램(플루르비프로펜)플록펜첩부제40밀리그램(플루르비프로펜)플루콕스펜플라스타(플루르비프로펜)케토톱액티브플라스타(플루르비프로펜)게보핏맥스플라스타(플루르비프로펜)안티푸라민40플라스타(플루르비프로펜)디펜파워투어펜플라스타(플루르비프로펜)요모겐트로키(플루르비프로펜)
Page 1 of 11
Services Offering Flurbiprofen
Companies Selling Flurbiprofen
한미
한미약품(주)Republic of Korea(주
(주)유한양행Republic of Korea삼진
삼진제약(주)Republic of Korea(주
(주)에이프로젠바이오로직스Republic of Korea(주
(주)대웅제약Republic of Korea일양
일양약품(주)Republic of Korea제이
제이더블유중외제약(주)Republic of Korea동화
동화약품(주)Republic of Korea(주
(주)녹십자Republic of Korea코오
코오롱제약(주)Republic of KoreaPage 1 of 8